Neoadjuvant chemotherapy in invasive breast cancer. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy8

Breast Axilla Cell Line, Tumor Lymph Nodes Tumor Cells, Cultured Mammary Glands, Human MCF-7 Cells Nipples

Organisms1

Diseases51

Breast Neoplasms Carcinoma, Ductal, Breast Neoplasm Invasiveness Carcinoma, Lobular Carcinoma, Intraductal, Noninfiltrating Lymphatic Metastasis Neoplasm Recurrence, Local Neoplasm Metastasis Carcinoma in Situ Carcinoma Carcinoma, Ductal Breast Diseases Adenocarcinoma Neoplasm, Residual Bone Neoplasms Osteosarcoma Disease Progression Breast Neoplasms, Male Esophageal Neoplasms Lung Neoplasms Neoplasms, Hormone-Dependent Ovarian Neoplasms Rectal Neoplasms Stomach Neoplasms Carcinoma, Squamous Cell Urinary Bladder Neoplasms Muscle Neoplasms Genetic Predisposition to Disease Neoplasms, Ductal, Lobular, and Medullary Uterine Cervical Neoplasms Neoplasms, Second Primary Fibrocystic Breast Disease Neoplasms Colorectal Neoplasms Liver Neoplasms Carcinoma, Non-Small-Cell Lung Pancreatic Neoplasms Carcinoma, Transitional Cell Prostatic Neoplasms Head and Neck Neoplasms Sarcoma Nasopharyngeal Neoplasms Mammary Neoplasms, Experimental Neovascularization, Pathologic Recurrence Ureteral Neoplasms Neutropenia Nausea Adenocarcinoma, Mucinous Neoplasms, Basal Cell Cell Transformation, Neoplastic

Chemicals and Drugs61

Receptors, Estrogen Receptor, erbB-2 Receptors, Progesterone Tumor Markers, Biological Doxorubicin Antineoplastic Agents Cisplatin Cyclophosphamide Taxoids Epirubicin Fluorouracil Tamoxifen Anthracyclines Paclitaxel Antineoplastic Agents, Hormonal Ki-67 Antigen Raloxifene Bridged Compounds Methotrexate Antibodies, Monoclonal, Humanized Deoxycytidine Biomarkers, Pharmacological Vinblastine Selective Estrogen Receptor Modulators Neoplasm Proteins Carboplatin Ifosfamide Organoplatinum Compounds Estrogen Receptor alpha Estrogen Receptor Modulators Fluorodeoxyglucose F18 Tumor Suppressor Protein p53 RNA, Messenger Aromatase Inhibitors Antibodies, Monoclonal Receptor, Epidermal Growth Factor Estrogens Antineoplastic Agents, Phytogenic Radiopharmaceuticals Antimetabolites, Antineoplastic Keratin-6 Etoposide Antibiotics, Antineoplastic BRCA2 Protein DNA, Neoplasm BRCA1 Protein Keratin-5 Antigens, Neoplasm Progestins Bleomycin Nitriles Mitomycin Dydrogesterone Leucovorin Antineoplastic Agents, Alkylating Estrogen Antagonists Camptothecin Tegafur Cadherins Triazoles Tumor Suppressor Proteins

Analytical, Diagnostic and Therapeutic Techniques and Equipment96

Neoadjuvant Therapy Chemotherapy, Adjuvant Antineoplastic Combined Chemotherapy Protocols Neoplasm Staging Prognosis Treatment Outcome Disease-Free Survival Combined Modality Therapy Mastectomy Mammography Survival Analysis Mastectomy, Segmental Survival Rate Immunohistochemistry Radiotherapy, Adjuvant Follow-Up Studies Retrospective Studies Prospective Studies Risk Factors Multivariate Analysis Neoplasm Grading Predictive Value of Tests Kaplan-Meier Estimate Proportional Hazards Models Lymph Node Excision Ultrasonography, Mammary Chemoradiotherapy, Adjuvant Risk Assessment Cohort Studies Case-Control Studies Cystectomy Incidence Sentinel Lymph Node Biopsy Esophagectomy Tissue Array Analysis Gene Expression Profiling Tumor Burden Odds Ratio Sensitivity and Specificity Risk Drug Administration Schedule Early Detection of Cancer Biopsy, Needle SEER Program Biopsy, Large-Core Needle Positron-Emission Tomography Reproducibility of Results Registries Radiotherapy In Situ Hybridization, Fluorescence Chemoradiotherapy Estrogen Replacement Therapy Reverse Transcriptase Polymerase Chain Reaction Biopsy Logistic Models Randomized Controlled Trials as Topic Multimodal Imaging Magnetic Resonance Imaging Mass Screening Immunoenzyme Techniques Clinical Trials as Topic Preoperative Care False Negative Reactions Hormone Replacement Therapy Tomography, X-Ray Computed Hysterectomy Oligonucleotide Array Sequence Analysis Mitotic Index Mammaplasty Feasibility Studies Pilot Projects Confidence Intervals Remission Induction Chi-Square Distribution Patient Selection Mammary Neoplasms, Experimental Questionnaires Statistics, Nonparametric Radiotherapy Dosage Probability Gastrectomy Mastectomy, Modified Radical Blotting, Western Mastectomy, Radical Breast Self-Examination Infusions, Intravenous Polymerase Chain Reaction Metastasectomy Hepatectomy ROC Curve Clinical Trials, Phase II as Topic Neoplasm Transplantation Xenograft Model Antitumor Assays Reproductive History Analysis of Variance Second-Look Surgery

Psychiatry and Psychology2

Breast Feeding Breast Self-Examination

Phenomena and Processes31

Gene Expression Regulation, Neoplastic Postmenopause Premenopause Time Factors Genes, erbB-2 Drug Resistance, Neoplasm Odds Ratio Sensitivity and Specificity Risk Genes, BRCA1 Menopause Cell Proliferation Genetic Predisposition to Disease Apoptosis Gene Amplification Cell Movement Mutation Chi-Square Distribution Germ-Line Mutation Breast Feeding Signal Transduction Parity Probability Genes, BRCA2 Dose-Response Relationship, Drug Genotype Phenotype Cell Division Polymorphism, Genetic Up-Regulation Down-Regulation

Disciplines and Occupations2

Immunohistochemistry Medical Oncology

Anthropology, Education, Sociology and Social Phenomena1

Quality of Life

Humanities1

Quality of Life

Information Science5

Survival Rate Incidence SEER Program Registries Questionnaires

Named Groups3

Survivors European Continental Ancestry Group African Americans

Health Care42

Treatment Outcome Disease-Free Survival Survival Analysis Survival Rate Follow-Up Studies Retrospective Studies Prospective Studies Risk Factors Multivariate Analysis Predictive Value of Tests Kaplan-Meier Estimate Proportional Hazards Models Risk Assessment Cohort Studies Case-Control Studies Incidence Age Factors Odds Ratio Sensitivity and Specificity Risk SEER Program Reproducibility of Results Registries Logistic Models Randomized Controlled Trials as Topic Mass Screening Clinical Trials as Topic Preoperative Care Feasibility Studies Pilot Projects Confidence Intervals Chi-Square Distribution Patient Selection Questionnaires Statistics, Nonparametric Confounding Factors (Epidemiology)Parity Probability ROC Curve Clinical Trials, Phase II as Topic Reproductive History Analysis of Variance

Geographicals3

United States California New Hampshire

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Information Science Named Groups Health Care Geographicals

Neoadjuvant Therapy Breast Neoplasms Chemotherapy, Adjuvant Carcinoma, Ductal, Breast Antineoplastic Combined Chemotherapy Protocols Neoplasm Invasiveness Breast Receptors, Estrogen Neoplasm Staging Receptor, erbB-2 Receptors, Progesterone Prognosis Carcinoma, Lobular Carcinoma, Intraductal, Noninfiltrating Treatment Outcome Disease-Free Survival Combined Modality Therapy Tumor Markers, Biological Lymphatic Metastasis Doxorubicin Antineoplastic Agents Mastectomy Mammography Neoplasm Recurrence, Local Cisplatin Survival Analysis Mastectomy, Segmental Cyclophosphamide Axilla Survival Rate Taxoids Epirubicin Immunohistochemistry Fluorouracil Tamoxifen Anthracyclines Radiotherapy, Adjuvant Follow-Up Studies Retrospective Studies Gene Expression Regulation, Neoplastic Cell Line, Tumor Neoplasm Metastasis Prospective Studies Risk Factors Carcinoma in Situ Postmenopause Carcinoma Paclitaxel Multivariate Analysis Antineoplastic Agents, Hormonal Ki-67 Antigen Carcinoma, Ductal Neoplasm Grading Predictive Value of Tests Kaplan-Meier Estimate Breast Diseases Premenopause Proportional Hazards Models Lymph Node Excision Ultrasonography, Mammary Adenocarcinoma Raloxifene Chemoradiotherapy, Adjuvant Risk Assessment Neoplasm, Residual Bone Neoplasms Osteosarcoma Bridged Compounds Cohort Studies Time Factors Methotrexate Case-Control Studies Cystectomy Lymph Nodes Genes, erbB-2 Drug Resistance, Neoplasm Disease Progression Incidence Sentinel Lymph Node Biopsy Breast Neoplasms, Male Antibodies, Monoclonal, Humanized Deoxycytidine Biomarkers, Pharmacological Vinblastine Esophagectomy Selective Estrogen Receptor Modulators Tissue Array Analysis Gene Expression Profiling Tumor Burden Esophageal Neoplasms Neoplasm Proteins Age Factors Lung Neoplasms Neoplasms, Hormone-Dependent Odds Ratio Sensitivity and Specificity Ovarian Neoplasms Risk Drug Administration Schedule Rectal Neoplasms

No FAQ available that match "neoadjuvant chemotherapy in invasive breast cancer"